123 related articles for article (PubMed ID: 16988527)
1. Crohn's disease onset in an HIV/hepatitis C virus co-infected woman taking pegylated interferon alpha-2b plus ribavirin.
Bongiovanni M; Ranieri R; Ferrero S; Casanova F; Monforte Ad
AIDS; 2006 Oct; 20(15):1989-90. PubMed ID: 16988527
[No Abstract] [Full Text] [Related]
2. [Efficacy and safety of pegylated-interferon plus ribavirin in HIV-infected patients co-infected with hepatitis C virus in clinical practice: a 32 cases observational follow-up].
Seydi M; Morlat P; Bonnet F; Rambeloarisoa J; Bernard N; Lacoste D; Bonarek M; Trimoulet P; Ramanampamonjy R; Lafon ME; Dramé M; Beylot J
Rev Med Interne; 2005 Apr; 26(4):280-7. PubMed ID: 15820563
[TBL] [Abstract][Full Text] [Related]
3. New paradigms in the management of hepatitis C virus co-infections.
Sherman KE
Nat Clin Pract Gastroenterol Hepatol; 2007 Jan; 4 Suppl 1():S10-6. PubMed ID: 17235280
[TBL] [Abstract][Full Text] [Related]
4. Pegylated interferon-alpha2a and ribavirin in HIV-hepatitis C coinfected patients.
Expert Rev Anti Infect Ther; 2004 Jun; 2(3):341-2. PubMed ID: 15490503
[No Abstract] [Full Text] [Related]
5. [Thrombotic thrombocytopenic purpura associated with interferon therapy in a HIV and HCV co-infected woman].
Michaux C; Randrianasolo D; Vandenhende MA; Hessamfar M; Morlat P; Bonnet F
Rev Med Interne; 2013 Dec; 34(12):773-5. PubMed ID: 23664070
[TBL] [Abstract][Full Text] [Related]
6. HIV & hepatitis C: treatment.
WORLD; 2002 May; (133):4-5. PubMed ID: 12064298
[No Abstract] [Full Text] [Related]
7. Co-infections. German doctors treat hepatitis C early, with some success.
TreatmentUpdate; 2006; 18(5):3-4. PubMed ID: 17209229
[No Abstract] [Full Text] [Related]
8. HCV infection in the setting of HIV: prevalence, disease, treatment.
Laurence J
AIDS Read; 2006 Mar; 16(3):115-6. PubMed ID: 16538952
[No Abstract] [Full Text] [Related]
9. [Report of three cases of hyperlactacidemiae/lactic acidosis after treatment of hepatitis C with pegylated interferon and ribavirin in HIV coinfected patients].
Montes Ramírez ML; Rodríguez Zapata M
Rev Clin Esp; 2002 Oct; 202(10):543-5. PubMed ID: 12361553
[TBL] [Abstract][Full Text] [Related]
10. [Treatment with pegylated interferon and ribavirin in patients co-infected by human immunodeficiency virus and hepatitis C virus].
Marcos Sánchez F; Albo Castaño MI; Casallo Blanco S
Rev Clin Esp; 2007 Mar; 207(3):150-1; author reply 151-2. PubMed ID: 17397643
[No Abstract] [Full Text] [Related]
11. Pegylated interferon alpha-2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients.
Callens S; Bottieau E; Michielsen P; Colebunders R
AIDS; 2004 Jan; 18(1):131. PubMed ID: 15090841
[No Abstract] [Full Text] [Related]
12. Response rates to pegylated interferon and ribavirin in HCV/HIV coinfection: a research synthesis.
Shire NJ; Welge JA; Sherman KE
J Viral Hepat; 2007 Apr; 14(4):239-48. PubMed ID: 17381715
[TBL] [Abstract][Full Text] [Related]
13. Results of a study of prolonging treatment with pegylated interferon-alpha2a plus ribavirin in HIV/HCV-coinfected patients with no early virological response.
Fuster D; Planas R; Gonzalez J; Force L; Cervantes M; Vilaró J; Roget M; García I; Pedrol E; Tor J; Ballesteros AL; Salas A; Sirera G; Videla S; Clotet B; Tural C
Antivir Ther; 2006; 11(4):473-82. PubMed ID: 16856621
[TBL] [Abstract][Full Text] [Related]
14. Severe weight loss in HIV / HCV-coinfected patients treated with interferon plus ribavirin: incidence and risk factors.
Bani-Sadr F; Lapidus N; Melchior JC; Ravaux I; Bensalem M; Rosa I; Cacoub P; Pol S; Perronne C; Carrat F
J Viral Hepat; 2008 Apr; 15(4):255-60. PubMed ID: 18307589
[TBL] [Abstract][Full Text] [Related]
15. Peginterferon alpha-2b plus ribavirin vs interferon alpha-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients.
Crespo M; Sauleda S; Esteban JI; Juarez A; Ribera E; Andreu AL; Falco V; Quer J; Ocaña I; Ruiz I; Buti M; Pahissa A; Esteban R; Guardia J
J Viral Hepat; 2007 Apr; 14(4):228-38. PubMed ID: 17381714
[TBL] [Abstract][Full Text] [Related]
16. Anti-HIV agents. Hepatitis C treatment and possible interactions with anti-HIV drugs.
TreatmentUpdate; 2004; 16(3):2-4. PubMed ID: 17216833
[No Abstract] [Full Text] [Related]
17. Care of patients with hepatitis C and HIV co-infection.
Soriano V; Puoti M; Sulkowski M; Mauss S; Cacoub P; Cargnel A; Dieterich D; Hatzakis A; Rockstroh J
AIDS; 2004 Jan; 18(1):1-12. PubMed ID: 15090824
[No Abstract] [Full Text] [Related]
18. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.
Torriani FJ; Rodriguez-Torres M; Rockstroh JK; Lissen E; Gonzalez-García J; Lazzarin A; Carosi G; Sasadeusz J; Katlama C; Montaner J; Sette H; Passe S; De Pamphilis J; Duff F; Schrenk UM; Dieterich DT;
N Engl J Med; 2004 Jul; 351(5):438-50. PubMed ID: 15282351
[TBL] [Abstract][Full Text] [Related]
19. Emergence of occult minority genotype 2b hepatitis C infection in an HIV-1-co-infected patient treated for genotype 5a HCV infection with 48 weeks of pegylated-interferon-alpha 2b and ribavirin.
Buckton AJ; Kulasegaram R; Ngui SL; Fisher M; James R; Rangarajan S; Teo CG
J Clin Virol; 2007 Sep; 40(1):60-3. PubMed ID: 17631045
[TBL] [Abstract][Full Text] [Related]
20. Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients.
Pineda JA; Mira JA; Gil Ide L; Valera-Bestard B; Rivero A; Merino D; Girón-González JA; Ríos-Villegas MJ; González-Serrano M; Collado A; García-García JA; Carrillo-Gómez R; López-Cortés LF; Gómez-Mateos J
J Antimicrob Chemother; 2007 Dec; 60(6):1347-54. PubMed ID: 17938129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
